Heart Failure
Showing NaN - NaN of 50
Heart Failure, Chronic Kidney Disease Trial in Worldwide (AZD9977, Dapagliflozin)
Recruiting
- Heart Failure
- Chronic Kidney Disease
-
Hot Springs National Park, Arkansas
- +279 more
Feb 1, 2023
Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Insufficiency Trial in Worldwide
Recruiting
- Tricuspid Regurgitation
- +5 more
-
St. Poelten, Niederoesterreich, Austria
- +27 more
Jan 26, 2023
Heart Failure Trial in Worldwide (V-Wave Interatrial Shunt, Control)
Active, not recruiting
- Heart Failure
- V-Wave Interatrial Shunt
- Control
-
Gilbert, Arizona
- +110 more
Jan 16, 2023
Heart Failure Trial in Worldwide (Ziltivekimab, Placebo)
Not yet recruiting
- Heart Failure
- Ziltivekimab
- Placebo
-
Alexander City, Alabama
- +420 more
Dec 23, 2022
Heart Failure Trial in Madrid
Recruiting
- Heart Failure
-
Madrid, SpainFundación Jiménez Dia University Hospital, IIS-FJD
Nov 21, 2022
Heart Failure Trial in Worldwide (sacubitril/valsartan)
Active, not recruiting
- Heart Failure
-
Loma Linda, California
- +78 more
Nov 18, 2022
Heart Failure, Heart Failure With Preserved Ejection Fraction Trial in Worldwide (LY3540378, Placebo)
Not yet recruiting
- Heart Failure
- Heart Failure With Preserved Ejection Fraction
- LY3540378
- Placebo
-
Tucson, Arizona
- +89 more
Nov 14, 2022
Type 2 Diabetes, Chronic Kidney Diseases Trial in Worldwide (Sotagliflozin (SAR439954), Placebo)
Heart Failure, Type 2 Diabetes Trial in Worldwide (Sotagliflozin (SAR439954), Placebo)
Terminated
- Heart Failure
- Type 2 Diabetes Mellitus
- Sotagliflozin
- Placebo
-
Alexander City, Alabama
- +465 more
Sep 30, 2022
Heart Failure Trial in Madrid (Bioimpedance analysis)
Completed
- Heart Failure
- Bioimpedance analysis
-
Madrid, SpainInstituto de Investigación Sanitaria de la Fundación Jiménez Día
Sep 12, 2022
Heart Failure Trial in Worldwide (Finerenone (BAY94-8862), Placebo)
Recruiting
- Heart Failure
- Finerenone (BAY94-8862)
- Placebo
-
Birmingham, Alabama
- +738 more
Aug 18, 2022
Heart Failure, Hyperkalemia Trial in Worldwide
Recruiting
- Heart Failure
- Hyperkalemia
-
Little Rock, Arkansas
- +84 more
Jun 2, 2022
Heart Failure Trial in Spain (Hypertonic saline solution plus intravenous furosemide, Intravenous furosemide)
Recruiting
- Heart Failure
- Hypertonic saline solution plus intravenous furosemide
- Intravenous furosemide
-
Majadahonda, Madrid, Spain
- +13 more
Apr 18, 2022
Implementation of Recommended Standards in Heart Failure
Recruiting
- Heart Failure
-
Oviedo, Asturias, Spain
- +5 more
Mar 16, 2022
Heart Failure, CHF Trial in Worldwide (device, procedure, diagnostic test)
Active, not recruiting
- Heart Failure
- Congestive Heart Failure
- Implant of investigational device system
- +3 more
-
Brussels, Belgium
- +20 more
Feb 28, 2022
Heart Failure Trial in Worldwide (Omecamtiv Mecarbil, Placebo, Standard of Care)
Completed
- Heart Failure
- Omecamtiv Mecarbil
- +2 more
-
Birmingham, Alabama
- +1033 more
Nov 2, 2021
Heart Failure Trial in Worldwide (MPP)
Terminated
- Heart Failure
- MPP
-
Huntsville, Alabama
- +205 more
Oct 28, 2021
Heart Failure, Anemia, Cardiovascular Disease Trial in Worldwide (Darbepoetin alfa, Placebo)
Completed
- Heart Failure
- +4 more
- Darbepoetin alfa
- Placebo
-
Birmingham, Alabama
- +753 more
Oct 31, 2021
Sleep Apnea, Heart Failure Trial in Worldwide (Adaptive Servo Ventilation)
Terminated
- Sleep Apnea
- Heart Failure
- Adaptive Servo Ventilation
-
Tucson, Arizona
- +48 more
Jul 9, 2021
Heart Failure Trial in Worldwide (Finerenone (BAY94-8862), Placebo, Inspra (eplerenone))
Completed
- Heart Failure
- Finerenone (BAY94-8862)
- +2 more
-
Birmingham, Alabama
- +171 more
Jul 2, 2021
Heart Failure Trial in Worldwide (Empagliflozin, Placebo)
Heart Failure Trial in Worldwide (Sentus QP left ventricular lead)
Terminated
- Heart Failure
- Sentus QP left ventricular lead
-
Fairhope, Alabama
- +118 more
Mar 1, 2021